期刊文献+

细胞因子IFN-γ、IL-6、IL-17和TGF-β1在Graves病发病中的作用 被引量:19

Study on levels of IFN-γ,IL-6,IL-17 and TGF-β1 in patients with Graves' disease
下载PDF
导出
摘要 目的:通过检测初发Graves病(GD)患者的IFN-γ、IL-6、IL-17和TGF-β1等4种细胞因子水平,研究Graves病的发病机制与细胞因子的关系。方法:对23例初发Graves病(GD组)的患者和23名健康对照者(NC组)的血清分别用ELISA法检测IFN-γ、IL-6、IL-17和TGF-β1浓度,用电化学发光法检测FT3、FT4和TSH水平,用放射受体分析法测定Tr Ab水平。结果:GD组与NC组之间年龄、性别均无统计学差异(t=0.334 8,P>0.05;χ2=0.410 7,P>0.05)。GD组IFN-γ、IL-6、IL-17和TGF-β1的浓度显著高于NC组,差异有统计学意义(P均<0.05);4种细胞因子与FT3、FT4均呈正相关(r=值依次为:0.324 6、0.453 2、0.431 0、0.463 8;0.413 2、0.441 5、0.436 2、0.467 1;P均<0.05);与TSH均呈负相关(r=值依次为-0.458 8、-0.482 8、-0.445 1、-0.493 0;P均<0.05)。结论:IFN-γ、IL-6、IL-17和TGF-β1等4种细胞因子在初发GD中均高表达;可能共同参与了GD的发病过程,可作为GD免疫功能紊乱的评价指标。 Objective:To explore the role of cytokines in the pathogenesis of Graves'disease ( GD), by detecting the levels of IFN-γ, IL-6, IL-17 and TGF-β1 in GD patients who were newly diagnosed. Methods: A total of 23 patients with new onset GD and 23 gender- and age-matched healthy controls were examined. The levels of serum IFN-γ, IL-6, IL-17 and TGF-β1 were measured by ELISA, FIB,FT4 and TSH levels were determined by ECL IA;TrAb levels were tested by RRA. Results: There were no significant difference among GD and NC group in sex and age match(t =0. 334 8 ,P〉0.05 ;X2 =0. 410 7 ,P〉0. 05). The levels of serum IFN-3,,IL- 6, IL-17 and TGF-~I in the GD group were significantly higher than the control group (P〈0. 05 ) . Correlation analysis revealed that IFN-γ,IL-6,IL-17 and TGF-β1 were positively correlated with FT3 ,FT4(r=0. 324 6,0. 453 2,0. 431 0,0. 463 8 ;0. 413 2,0. 441 5, 0.436 2,0.467 I; P〈0.05). Conclusion: IFN-γ, IL-6, IL-17 and TGF-β1 are highly expressed in the newly diagnosed GD patients. They play an important role in the pathogenesis of GD, and provide helpful evaluation indices of immune dysfunction to Graves disease.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2015年第2期253-256,共4页 Chinese Journal of Immunology
关键词 GRAVES病 细胞因子 白介素17 转化生化因子β1 发病机制 Graves 'disease Cytokine Interleukin 17 Transforming growth-beta Pathogensis
  • 相关文献

参考文献18

  • 1Jacobson EM, Tomer Y. The genetic basis of thyroid autoimmunity [ J]. Thyroid ,2007,17 (lO) 949-961.
  • 2杨士军,谭维琴,刘满庆,王文亮.动态检测TRAb、TPOAb、TGA在Graves'病诊治中的临床价值[J].西部医学,2009,21(4):618-620. 被引量:5
  • 3Lantz M, Planck T, Asman P, et al. Increased TRAb and/or low anti-TPO titers at diagnosis of graves'disease are associated with an increased risk of developing ophthalmopathy after onset [ J ]. Exp Clin Endocrinol Diabetes ,2014,122 ( 2 ) : 113-117.
  • 4Esfahanian F, Naimi E, Doroodgar F, et al. Thl/Th2 cytokines in patientswith Graves'disease with or without ophthalmopathy [ J ] Iran J Allergy Asthmalmmunol,2013,12(2) :168-175.
  • 5Peng D,Xu B,Wang Y,et al. A high frequency of circulating th22 and thl7 cells in patients with new onset graves'disease[ J]. PLoS One,2013,8(7) :e68446.
  • 6Yamamoto K, Itoh M, Okamura T, et al. Relative levels of the in- flammatory cytokine TNFα and the soluble CD40 ligand profile in serum correlate with the thyrotoxic activity of Graves'disease [ J ]. Thyroid ,2012,22 ( 5 ) :516-521.
  • 7中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:817
  • 8马学芹,于世鹏.初发Graves病患者^(131)I治疗前后IL-23/Th17轴相关因子水平的变化及意义[J].中国免疫学杂志,2013,29(7):733-735. 被引量:10
  • 9Zhou J,Bi M,Fan C,et al. Regulatory T cells but not T helper 17 ceils are modulated in an animal model of Graves'hyperthyroidism [ J ]. Clin Exp Med ,2012,12 ( 1 ) :39-46.
  • 10Inoue A, Koizumi S, Matsuda A, et (tl. Graves' hyperthyroidism showing transient hypothyroidism during interferon therapy for chronic hepatitis type C [ J ]. Endocr J,2005,52 ( 3 ) :293 -298.

二级参考文献42

  • 1王胜军,许化溪,王永忠,胡嘉波,马斌.CD4^+CD25^+调节性T细胞抑制小鼠自身免疫性甲状腺炎的发生[J].中国免疫学杂志,2005,21(2):102-104. 被引量:7
  • 2刘超,张忠邦.甲状腺特异性抗体[J].中华内分泌代谢杂志,1994,10(1):28-30. 被引量:31
  • 3蔡永君,孙文佶.调节性T细胞的研究进展[J].浙江大学学报(医学版),2006,35(5):568-572. 被引量:4
  • 4陈彬.医学文稿中论著的统计学处理与基本要求[J].西部医学,2007,19(4):755-755. 被引量:77
  • 5陆再英,钟南山,谢毅,等.内科学[M].7版.北京:人民卫生出版社,2010:125-126.
  • 6Saitoh O,Nagayania Y.Regulation of Graves’s hyperthroidism withnaturally occurring CD4+CD25+regulatory T cell in a mouse model[J].Endocrinology,2006,147(5):2417-2422.
  • 7Fontenot JD,Gavin MA,Rudensky AY.Foxp3 programs the devel-opment and function of CD4+CD25+regulatory T cells[J].Nat Im-munol,2003,4(4):330-336.
  • 8Khattri R,Cox T,Yasayko SA,et al.An essential role for scurfinin CD4+CD25+regulatory T cells[J].Nat Immunol,2003,4(4):337-342.
  • 9Wang H,Zhao S,Tang X,et al.Changes of regulatory T cells inGraves'disease[J].Huazhong Univ Sci Technolog Med Sci,2006,26(5):545-547.
  • 10Marie JC,Letterio J,Gavin M,et al.TGF-β1 maintains suppressorfunction and Foxp3 expression in CD4+CD25+regulatory T cells[J].J Exp Med,2005,201(7):1061-1067.

共引文献843

同被引文献173

引证文献19

二级引证文献161

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部